BioSpyder Technologies Inc. has developed a novel product for targeted sequencing called TempO-Seq™, a gene expression profiling tool designed to monitor hundreds to thousands of genes at once in high throughput. TempO-Seq can analyze expression in samples with thousands of cells or from single cells without pre-amplification, maximizing utilization of precious or limited samples. Sample barcoding, together with sequencing short fragments of each gene, enables pooling up to 6,144 samples in one sequencing run. Assay content is flexible and customizable delivering unprecedented accuracy and sensitivity with simplified data analysis that eliminates the need for bioinformatics. TempO-Seq assays deliver an easy to use solution for customers doing expression profiling for any species.

Contact us

Contact us for more information on how to implement molecular endpoints to your high-throughput studies.

Bring whole transcriptome profiling to your lab.
TempO-Seq opens new worlds of science to almost any genomics lab. Suddenly large scale studies are both affordable and practical, thanks to high target content, high sample throughput, and simple data analysis.

Toxicology

Making chemical safety better

Toxicology is one of life science’s most demanding frontiers, where subtle exposures can drive big biological changes and traditional endpoints don’t always tell the full story. TempO-Seq reveals how cells and tissues respond at the gene expression level, delivering clearer mechanistic insight and faster, more confident safety decisions across discovery, development, and regulatory workflows.

Pharma

Making it easier to do drug development

Early compound screening is one of pharma’s highest-leverage decision points, where subtle biological signals can determine whether a candidate moves forward or becomes a costly late-stage failure. TempO-Seq delivers high-throughput, gene expression profiling to show how compounds impact biology early, enabling faster, more confident safety and go/no-go decisions.

Oncology

Helping in the fight against cancer

Oncology research is one of biomedicine’s most challenging arenas, where tumors evolve quickly and responses can vary dramatically from patient to patient. TempO-Seq reveals the gene expression programs driving cancer behavior and treatment response, enabling clearer biomarker discovery, mechanism insight, and more confident decisions across research and translational studies.

Computational Biology

Simplifying data analysis

Computational biology is transforming how we interpret high-dimensional screening data, turning raw transcriptomic profiles into actionable predictions. By combining TempO-Seq’s scalable gene expression readouts with machine-learning models, researchers can classify biological responses, predict molecular initiating events, and uncover mechanistic patterns that traditional endpoints may miss. This enables faster prioritization, better hazard prediction, and more confident decision-making from early screening through advanced research workflows.